军事知识服务平台
患者报告结局测量工具在炎症性肠病中的应用及选择策略
Application and selection strategies of patient-reported outcome measure in inflammatory bowel disease
摘要 患者报告结局测量工具(PROM)作为系统量化患者主观健康体验的核心工具,在炎症性肠病(IBD)精准管理中具有重要价值。本文对IBD领域主要PROM进行梳理,涵盖疾病特异性工具(SIBDQ、IBD-Control、CD-PRO/SS和UC-PRO/SS、IBD-Disk、IBD-DS)与通用工具(EQ-5D-5L、PROMIS、PHQ-9),分析各工具的测量特性与适用场景,提出基于不同临床场景的选择整合策略框架,并探讨PROM在疾病监测、临床试验终点、远程管理及临床决策中的应用价值。目前PROM在IBD领域的推广仍面临标准化不足、跨文化适配不完善及数字化实施障碍等挑战。未来应推动符合中国国情的IBD特异性PROM的开发与验证,深化其与临床路径的整合,以实现真正以患者为中心的精准管理。
Abstract:
Patient-reported outcome measure(PROM)systematically quantify patients' subjective health experiences and is central to precision management of inflammatory bowel disease(IBD). This article reviews major PROM in IBD,including disease-specific tools(SIBDQ,IBD-Control,CD-PRO/SS and UC-PRO/SS,IBD-Disk,IBD-DS)and generic tools(EQ-5D-5L,PROMIS,PHQ-9),analyzes their measurement properties and appropriate applications,and proposes a clinical scenario-based framework for tool selection and integration,explore the application value of PROM in disease monitoring,clinical trial endpoints,remote management and clinical decision-making. Key challenges include insufficient standardization,incomplete cross-cultural adaptation,and barriers to digital implementation. In the future,efforts should be made to develop and validate IBD-specific PROM suitable for China's national conditions,and further integrate them into clinical pathways to achieve true patient-centered precision management.